MoneyWorks4Me

Kilitch Drugs (India) informs about press release

23 Oct 2026 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kilitch Drugs (India) has informed that it enclosed a Press Release relating to the proposed divestment of entire stake in the overseas subsidiary which the company shall be releasing immediately after intimation to the exchanges.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..